DK0683791T3 - Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf - Google Patents

Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf

Info

Publication number
DK0683791T3
DK0683791T3 DK94906253T DK94906253T DK0683791T3 DK 0683791 T3 DK0683791 T3 DK 0683791T3 DK 94906253 T DK94906253 T DK 94906253T DK 94906253 T DK94906253 T DK 94906253T DK 0683791 T3 DK0683791 T3 DK 0683791T3
Authority
DK
Denmark
Prior art keywords
albumin
pct
protein composition
agent
aqueous
Prior art date
Application number
DK94906253T
Other languages
English (en)
Inventor
Elie Stefas
Marcel Rucheton
Hubert Graafland
Original Assignee
Apoh Technologies Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apoh Technologies Sa filed Critical Apoh Technologies Sa
Application granted granted Critical
Publication of DK0683791T3 publication Critical patent/DK0683791T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK94906253T 1993-02-09 1994-02-09 Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf DK0683791T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9301399A FR2701263B1 (fr) 1993-02-09 1993-02-09 Procédé d'obtention d'une composition aqueuse protéinique, composition correspondante, glycoprotéine contenue et son utilisation pour la stabilisation de l'albumine et la détection ou le dosage d'anticorps.
PCT/FR1994/000143 WO1994018228A1 (fr) 1993-02-09 1994-02-09 Composition aqueuse proteinique, glycoproteine contenue, procede d'obtention et utilisations

Publications (1)

Publication Number Publication Date
DK0683791T3 true DK0683791T3 (da) 2004-05-03

Family

ID=9443864

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94906253T DK0683791T3 (da) 1993-02-09 1994-02-09 Vandig proteinsammensætning, glycoprotein indeholdt deri, fremgangsmåde til opnåelse deraf og anvendelser deraf

Country Status (8)

Country Link
US (1) US5859213A (da)
EP (1) EP0683791B1 (da)
AT (1) ATE263779T1 (da)
DE (1) DE69433682T2 (da)
DK (1) DK0683791T3 (da)
ES (1) ES2215164T3 (da)
FR (1) FR2701263B1 (da)
WO (1) WO1994018228A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
JP3308173B2 (ja) * 1996-11-07 2002-07-29 松下電器産業株式会社 尿検査方法およびそれに用いる尿検査装置
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
CA2376057A1 (en) * 1999-06-08 2000-12-14 La Jolla Pharmaceutical Company Valency platform molecules comprising aminooxy groups
CA2414076A1 (en) 2000-06-08 2001-12-13 La Jolla Pharmaceutical Company Multivalent platform molecules comprising high molecular weight polyethylene oxide
FR2827047B1 (fr) * 2001-07-03 2003-09-26 Apoh Technollgies Sa Procede de separation et/ou detection et/ou identification et/ou quantification de proteines prions
CN101146826A (zh) * 2005-01-24 2008-03-19 得克萨斯大学体系董事会 与磷脂酰丝氨酸结合的fc融合构建体及其治疗用途
CA2833907A1 (en) * 2011-05-10 2012-11-15 Advanced Liquid Logic, Inc. Enzyme concentration and assays
WO2013009927A2 (en) 2011-07-11 2013-01-17 Advanced Liquid Logic, Inc. Droplet actuators and techniques for droplet-based assays
US20240002470A1 (en) 2020-08-11 2024-01-04 Apoh-Technologies Method for separation and/or detection and/or in vitro quantification of infectious compounds in biological material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (da) * 1978-11-24 1982-12-04 Hoffmann La Roche
FR2541593B1 (fr) * 1983-02-25 1988-06-17 Rhone Poulenc Spec Chim Support mineral poreux pour la purification et le fractionnement des macromolecules biologiques

Also Published As

Publication number Publication date
DE69433682D1 (de) 2004-05-13
US5859213A (en) 1999-01-12
ATE263779T1 (de) 2004-04-15
DE69433682T2 (de) 2005-04-21
WO1994018228A1 (fr) 1994-08-18
FR2701263B1 (fr) 1995-04-21
FR2701263A1 (fr) 1994-08-12
ES2215164T3 (es) 2004-10-01
EP0683791B1 (fr) 2004-04-07
EP0683791A1 (fr) 1995-11-29

Similar Documents

Publication Publication Date Title
Weiss et al. Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography
Givol et al. General method for the specific isolation of peptides containing modified residues, using insoluble antibody columns
Fearon Purification of C3b inactivator and demonstration of its two polypeptide chain structure
US4217339A (en) Glycoprotein and process for isolating it
US4341764A (en) Method of preparing fibronectin and antihemophilic factor
Michaelis Partial purification and characterization of a glutamate-binding membrane glycoprotein from rat brain
JP2509407B2 (ja) 生物学的に活性な化合物の単離方法
US4269825A (en) New glycoprotein and process for isolating it
Perez et al. Enhancement of the chemotactic activity of human C5a des Arg by an anionic polypeptide (" cochemotaxin") in normal serum and plasma.
Kiron et al. Purification and properties of a soluble angiotensin II-binding protein from rabbit liver
DE69433682T2 (de) Wässrige proteinzusammensetzung, enthaltend glykoproteine, verfahren zur herst ellung und verwendungen
Rauh et al. Calmodulin is a major component of extruded trichocysts from Paramecium tetraurelia.
Gordon et al. Refinement of fluorescent antibody by gel filtration.
Calero et al. Location of a novel type of interpolypeptide chain linkage in the human protein HC-IgA complex (HC-IgA) and identification of a heterogeneous chromophore associated with the complex.
Gonmori et al. Properties of human tissue thromboplastins from brain, lung, arteries, and placenta
Stathakis et al. Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains
Khalil-Manesh et al. Aluminum-Binding Protein in Dialysis Dementia. I. Characterization in Plasma by Gel Chromatography and Electrophoresis: I. Characterization in Plasma by Gel Chromatography and Electrophoresis
CHU et al. Interaction of parathyroid hormone with membranes of kidney cortex: Degradation of the hormone and activation of adenylate cyclase
Roth et al. Human platelet glycoprotein V: a surface leucine-rich glycoprotein related to adhesion
Kitagawa et al. Separation of antibodies into fractions with different binding properties
US4018885A (en) Steroid-binding globulin and process for preparing it and antibodies thereto
Burton et al. Progesterone-binding globulin from the serum of pregnant guinea pigs, a polydisperse glycoprotein
FI78483B (fi) Rening av modulatorer foer immunsystem.
BEALL et al. Serum protein inhibition of thyrotropin binding to human thyroid tissue
Minta Purification of native properdin by reversed affinity chromatography and its activation by proteolytic enzymes